Translated title of the contributionEfficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study
Original languageRussian
Pages (from-to)412-421
Number of pages10
JournalФАРМАКОЭКОНОМИКА. СОВРЕМЕННАЯ ФАРМАКОЭКОНОМИКА И ФАРМАКОЭПИДЕМИОЛОГИЯ
Volume16
Issue number3
DOIs
StatePublished - 10 Nov 2023

ID: 115181944